Novartis commits $7.5 million to the "Blitz the Barriers" campaign, aiming to raise awareness and encourage early testing for ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

Beyoncé’s dad teamed up with ZERO Prostate Cancer to tackle the disease. Learn how this game-changing campaign is breaking stigma, expanding screenings and saving lives.

ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

In radioligand therapies, Novartis is waiting to hear back from the FDA on its application for PSMA-targeted Pluvicto in pre-taxane metastatic castration-resistant prostate cancer. After an early ...

Over 90% adherence to relugolix in patients with Medicare with prostate cancer for 24 months supports its use as androgen ...